Kyowa Kirin Co Ltd KYKOF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if KYKOF is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $17.25
- Day Range
- $17.75–17.80
- 52-Week Range
- $15.78–20.31
- Bid/Ask
- $18.61 / $22.87
- Market Cap
- $9.39 Bil
- Volume/Avg
- 5,630 / 2,482
Key Statistics
- Price/Earnings (Normalized)
- 12.91
- Price/Sales
- 3.04
- Dividend Yield (Trailing)
- 2.09%
- Dividend Yield (Forward)
- 2.12%
- Total Yield
- 3.05%
Company Profile
Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Core
- Total Number of Employees
- 5,974
- Website
- http://www.kyowa-kirin.com
Comparables
Valuation
|
Metric
|
KYKOF
|
4516
|
4554
|
|---|---|---|---|
Price/Earnings (Normalized) | 12.91 | 9.00 | 11.86 |
Price/Book Value | 1.71 | 1.05 | 0.76 |
Price/Sales | 3.04 | 1.56 | 0.77 |
Price/Cash Flow | 11.56 | 10.17 | 4.65 |
Price/Earnings
KYKOF
4516
4554
Financial Strength
|
Metric
|
KYKOF
|
4516
|
4554
|
|---|---|---|---|
Quick Ratio | 2.88 | 3.11 | 0.55 |
Current Ratio | 3.54 | 4.40 | 1.24 |
Interest Coverage | 272.80 | 101.20 | 58.74 |
Quick Ratio
KYKOF
4516
4554
Profitability
|
Metric
|
KYKOF
|
4516
|
4554
|
|---|---|---|---|
Return on Assets (Normalized) | 10.16% | 10.26% | 4.98% |
Return on Equity (Normalized) | 12.55% | 12.13% | 10.16% |
Return on Invested Capital (Normalized) | 11.74% | 11.86% | 6.17% |
Return on Assets
KYKOF
4516
4554
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| Xhjfrzpzn | Tmng | $724.5 Bil | |||
| Johnson & Johnson
JNJ
| Nzghfpkj | Lnnl | $386.7 Bil | |||
| AbbVie Inc
ABBV
| Qrpzkwlcb | Ndqt | $327.0 Bil | |||
| Merck & Co Inc
MRK
| Qpfkzjs | Vjg | $317.3 Bil | |||
| Roche Holding AG ADR
RHHBY
| Lznrvztgd | Yrwm | $261.9 Bil | |||
| AstraZeneca PLC ADR
AZN
| Rlxnckvr | Slz | $242.7 Bil | |||
| Novartis AG ADR
NVS
| Jkvzkrrq | Qtd | $224.0 Bil | |||
| Amgen Inc
AMGN
| Vvrgfdnfsv | Zgpr | $179.6 Bil | |||
| Pfizer Inc
PFE
| Wtycdtxc | Zrwv | $174.4 Bil | |||
| Sanofi SA ADR
SNY
| Jfbxtwx | Bybl | $132.4 Bil |